NADP
@NADP_AMR
Followers
126
Following
64
Media
35
Statuses
147
NADP (Netherlands Antibiotic Development Platform) facilitates public-private collaborations to accelerate development of antibiotics and alternative therapies
Utrecht, Nederland
Joined January 2017
We at @UMCUtrecht are extremely proud! The Royal Netherlands Academy of Arts and Sciences (@_knaw) has elected prof dr @MarcBonten as a new member. KNAW members are leading scientists from all disciplines and are selected based on their scientific merits https://t.co/bQP3TIrMuE
3
3
33
WHO: No antibiotic in development sufficiently addresses drug resistance
healio.com
None of the 43 traditional antibiotics in the clinical pipeline that target WHO priority pathogens, Clostridioides difficile or tuberculosis sufficiently addresses drug resistance, according to a new...
0
5
5
Gut microbiota composition can be used to recognize patients at increased risk of infection with C. difficile after #antibiotics treatment, concludes a study coordinated by @hvwerkhoven from @UMCUtrecht published today in @natcoms
https://t.co/q8gvPBRZ1y
@MarcBonten @COMBACTE
0
9
27
This Thursday March 4, @gardp_amr will host a free webinar to discuss how we can apply the lessons learned from #COVID-19 to tackle drug resistance and ensure access to appropriate #antibiotics. Be sure to register and share with your networks: https://t.co/OGckpqP4ji
0
20
28
On March 1st, the European Clinical Research Alliance for Infectious Diseases (ECRAID-base) will start activities. It aspires to become in 5 yrs a pan-European clinical research network for infectious diseases and evolve into a self-sustaining academic CRO https://t.co/O0zyzRJBxT
2
5
18
JPIAMR organizes from April 20-22, 2021 a workshop led by the UK @The_MRC, titled "Feeding the #AMR Therapeutics Pipeline". The workshop will discuss new strategies for the treatment of infection and identification of resistant microbes. For details, go to https://t.co/LejUsvTwzJ
0
0
2
We’re excited to announce the announce the activation of the first site in South Africa as part of our global phase 3 trial of zoliflodacin, a novel, first-in-class treatment for #gonorrhoea. Learn more: https://t.co/0IAFM04Kzf
#StopSuperBugs #AMR
0
4
11
Clonal dissemination appears to be the major driver of one type of resistance of Enterococcus faecium against the antibiotic vancomycin (VRE). This was concluded by @AnitaSchurch, @Sergi_Arredondo and colleagues @UMCUtrecht in Genome Medicine https://t.co/nrw4o8sYB7
@MarcBonten
1
6
15
Infections with Gr- bacteria (e.g. E. coli) cause significant mortality (>2,000 deaths/year) in countries with a low #AMR pressure such as the Netherlands, wrote Tim Deelen @juliuscenter in his PhD thesis that he defended today at @UniUtrecht
https://t.co/VH44ERE3jH
@MarcBonten
0
3
13
We are proud! Prof. Suzan Rooijakkers @UMCUtrecht, member of the @NADP_AMR Executive Board, today received a prestigeous @ERC_Research Consolidator Grant to fight AMR, focusing on antibodies against E. coli.
Please join me in congratulating Suzan Rooijakkers, professor of microbiology @UMCUtrecht, who received today a € 2M Consolidator Grant from @ERC_Research to identify antibodies that use the immune system to fight E. coli infections https://t.co/gxCBl5NPsE
@MarcBonten #ERCCoG
0
0
0
This wednesday starts World Antimicrobial Awareness Week. On Nov 19 (15-16 hrs.) @ncohnl and @NADP_AMR jointly organize a webinar titled ‘Silent pandemic: Antimicrobial Resistance (AMR)’. For more info and registration, go to
ncoh.nl
Time: 15:00 – 16:00 (CET) As the Covid-19 pandemic ploughs on, a slower-acting pandemic may follow closely behind. Prior to the emergence of the novel coronavirus, the development of antibiotic...
0
0
2
Interesting . . . The not-for-profit Global Antibiotic Research and Development Partnership (@gardp_amr) organizes a live webinar on November 17 (17.00-18.00 hours CET) on the use of artificial intelligence in the development of novel #antibiotics
Interested in Artificial Intelligence? Find out how it can be used to discover new antibiotics and prevent #AMR. Register for the webinar here: https://t.co/ckPeyd1N4W
0
4
0
We congratulate @NADP_AMR executive board member Cornelis Boersma with his appointment as extraordinary professor of Sustainable Care and Innovation at Open University. https://t.co/DvliYIR02p
@OU_Nederland @ncohnl
0
2
3
29 OCT 2020: FIRST VIRTUAL NCOH ASM. Do we need a new scientific approach to prevent diseases or a new pandemic? Hosted by @MarionKoopmans and @HeimanW with @ErasmusMC @RadboudUMC @RIVM @WUR @VUamsterdam. Register now! https://t.co/dB3wNSMEbs
#NCOH #COVID_19 #OneHealth
2
15
22
WORK! Postdoctoral researcher microbial bioinformatics and infectious diseases.
academictransfer.com
Vancomycin-resistant Enterococcus faecium (VRE) are causative agents of health-care-associated infections and are of growing concern worldwide. The candidate will further develop a user-friendly...
0
9
6
5.7 million people die every year from treatable bacterial diseases due to the lack of access to #antibiotics; another 700,000 die from #antimicrobialresistance. What is #pharma doing about it? See the methodology for our 2021 #AMR Benchmark, now online: https://t.co/PHZkZK4vit
0
13
9
NEW: The rise of #AMR poses threats to modern medicine & our way of living. The methodology for the 2021 AMR Benchmark enables the tracking of #pharma's progress against #superbugs & a deeper exploration of the headwinds faced by biotechs driving novel R&D https://t.co/PHZkZK4vit
2
16
25